Fellows

Fellows in Committee on Clinical Pharmacology and Pharmacogenomics

Mohamed Ali, PhD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest:
Clinical Pharmacology and Translational Science. Focus on exposure-response analysis, PK modeling, and dose optimization through alternative dosing strategies in oncology, particularly within early-phase clinical trials to enhance efficacy, safety, and cost-effectiveness.

Research Mentor: Mark Ratain, MD

Robert Cameron, MD, PhD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Identification of metabolic vulnerabilities within tumors to develop new therapeutic targets and combinations

Research Mentors: Brandon Faubert, PhD and Marina Garassino, MD

Joseph Cannova, MD, PhD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Investigating mechanisms of recurrent cytogenetic alterations in therapy-related myelodysplastic syndrome and acute myeloid leukemia with loss of chromosome 7 domains.

Research Mentor: Michael Drazer, MD, PhD

Youngwoo Cho, PharmD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Translation of pharmacogenomics (PGx) in clinical oncology, early-phase clinical development, and pharmacokinetics (PK) and pharmacodynamics (PD) of immunotherapy

Research Mentor: Peter H. O’Donnell, MD

Sulin Wu, MD, PhD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Therapeutic design informed by germline and somatic profiles associated with immune therapy resistance and intolerance; Biomarker discovery; Early phase trials

Research Mentor: Olufunmilayo Olopade, MD, FACP